UBS analyst Peter Grom lowered the firm’s price target on Scotts Miracle-Gro (SMG) to $68 from $71 and keeps a Neutral rating on the shares. The company reported a fiscal Q3 earnings beat on stronger gross margin, but its sales missed consensus forecasts, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMG: